Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment Period	STARTED	BAF312	16
Treatment Period	STARTED	Placebo	13
Treatment Period	COMPLETED	BAF312	8
Treatment Period	COMPLETED	Placebo	10
Treatment Period	NOT COMPLETED	BAF312	8
Treatment Period	NOT COMPLETED	Placebo	3
Safety Follow-Up Period	STARTED	BAF312	16
Safety Follow-Up Period	STARTED	Placebo	13
Safety Follow-Up Period	COMPLETED	BAF312	14
Safety Follow-Up Period	COMPLETED	Placebo	12
Safety Follow-Up Period	NOT COMPLETED	BAF312	2
Safety Follow-Up Period	NOT COMPLETED	Placebo	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03338998/flow